The photomedicine market, valued at USD 2.85 Billion in 2022, is projected to reach USD 5.95 Billion by 2032, with a forecasted compound annual growth rate (CAGR) of 8.5%. The market's expansion is primarily fueled by the increasing prevalence of chronic ailments like cancer, skin conditions, and neurological disorders. Photomedicine, a non-invasive therapeutic approach utilizing light energy, has gained significant popularity due to its effectiveness, absence of adverse effects, and non-intrusiveness. Moreover, the growing elderly population and the growing awareness of the benefits of light therapy have contributed to the surge in demand for photomedicine.https://www.reportsanddata.com..../report-detail/photo
Like
Comment
Share
